A test measuring proteins in spinal fluid may help support the diagnosis of MS, especially in patients whose disease is harder to diagnose.

Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.

Explore what is driving progress in neurological biomarker research today, from emerging technologies to clinical translation ...

Brain-derived extracellular vesicle (EV) biomarkers represent a promising frontier for liquid biopsy development targeting the nervous system. They offer strong potential for enabling minimally ...

Neurodegeneration often progresses silently before diagnosis and is influenced by a variety of systemic variables other than the brain, such as cardiovascular failure, chronic inflammation, oxidative ...